Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Obesity clinical trial success rates for novel drugs U.S. 2006-2015 by phase

This statistic depicts the percentage of obesity clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. According to the data, among obesity NME/biologics just 1.4 percent were successful from phase I to approval.

Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

United States

Survey time period

2006 to 2015

Supplementary notes

NDA/BLA = new drug application/biologic license application
NME = new molecular entity

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Diabetes in the U.S."

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.